CORDIS
EU research results

CORDIS

English EN

Novel approaches for the development of customized skin treatments and services (Test case: Dead Sea Minerals and Conventional drugs)

Objective

Economical and health interests of skin problems are fast growing issues in Europe, following the remarkable extension in life expectancy in western countries, together with the increased awareness of UV radiation risks. Personalized health care approach has been discussed over the past few years and had been accompanied by developing innovative technologies capable of identifying specific biomarkers, supporting a personalized diagnosis and treatments, especially concerning bio-compatibility of drugs. Skin Treat intends to develop and validate nano-chemical and bio- technologies to achieve an accurate matching of drugs, and drug delivery vehicles, to skin diseases and sub pathogenic skin conditions in their individual context. The project will design novel generation of pharmaceutical products, as well as consumer personalized service, in order to fit customers’ tailored needs with a support of strategic consortium based on partnership among SMEs and research organizations. The development of personalized skin therapy protocols requires achieving an accurate diagnostics of skin condition and an extensive analysis of biological markers. Non invasive methods as well as minimal invasive skin sampling, will support the establishment of a range of biological profiles corresponding to skin diseases and skin sub pathologic conditions. Statistical processing of these data will allow defining biomarkers patterns specifically associated with given clinical conditions. A bio-informatics data mining protocol will be elaborated, together with multifunctional biomarker analysis software, to build a refined, personalized diagnosis method. Finally, the computer data analysis will yield a decision support system (DSS) to assist dermatologists, chemist and clients for prescription of personalized treatment. Skin Treat concept will be evaluated by a wet pilot study of the whole ervice chain on a few, selected skin disorders like psoriasis, contact dermatitis, and UV skin photo-aging damages.
Leaflet | Map data © OpenStreetMap contributors, Credit: EC-GISCO, © EuroGeographics for the administrative boundaries

Coordinator

AHAVA DEAD SEA LABORATORIES LTD

Address

Arava Street 1
70150 Airport City

Israel

Activity type

Private for-profit entities (excluding Higher or Secondary Education Establishments)

EU Contribution

€ 559 575

Administrative Contact

Ofer Achdut (Mr.)

Participants (14)

Sort alphabetically

Sort by EU Contribution

Expand all

STRATICELL SCREENING TECHNOLOGIES

Belgium

EU Contribution

€ 334 000

SISTEMAS GENOMICOS SL

Spain

EU Contribution

€ 153 550

UNIVERSITA DI PISA

Italy

EU Contribution

€ 329 856

THE HEBREW UNIVERSITY OF JERUSALEM

Israel

EU Contribution

€ 492 820

STIFTELSEN SINTEF

Norway

EU Contribution

€ 336 084

DERMATEST GESELLSCHAFT FUR ALLERGOLOGISCHE FORSCHUNG U VERTRIEB VON KORPERPFLEGEMITTELN MBH

Germany

EU Contribution

€ 391 140

FUNDACION GAIKER

Spain

EU Contribution

€ 233 131

TROYKA MAKINA GIDA INSAAT MUHENDISLIK ENERJI CEVRE BILISIM ARASTIRMA GELISTIRME DANISMANLIK SANAYI VE PAZARLAMA LIMITED SIRKETI

Turkey

EU Contribution

€ 138 288

MAPI-NAXIS SAS

France

EU Contribution

€ 85 696

OSM-DAN LTD

Israel

EU Contribution

€ 180 000

INI-NOVATION UK LIMITED

United Kingdom

EU Contribution

€ 61 187

AFCON HOLDINGS LTD

Israel

EU Contribution

€ 348 084

A. BERENTS GMBH & CO KG

Germany

EU Contribution

€ 209 952

WINZSOFT (ISRAEL) LTD

Israel

EU Contribution

€ 96 672

Project information

Grant agreement ID: 213202

Status

Closed project

  • Start date

    1 September 2008

  • End date

    31 August 2012

Funded under:

FP7-NMP

  • Overall budget:

    € 5 446 376,80

  • EU contribution

    € 3 950 035

Coordinated by:

AHAVA DEAD SEA LABORATORIES LTD

Israel

This project is featured in...